The volume of the stock is concerning. With 1.4+ BILLION shares on issue one would think trades would be significantly higher in volume / amounts.
Did those biotech talk fests achieve anything recently? Were new eye balls attracted to the stock?
Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-27
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.75 |
Change
-0.250(1.39%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.75 | $8.997K | 501 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 477 | $17.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 354 | 3 |
View Market Depth
| Last trade - 10.58am 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |